التداخل بين إنالابريل وهيدروكلوروثيازيد وبوليستيرين سلفونات الصوديوم

Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.

Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes, which should be used cautiously, if at all, with enalapril (see Drug Interactions ).

Hyperkalemia Patients should be told not to use salt substitutes containing potassium without consulting their physician.